Home » Newsletters » BioWorld Science

BioWorld Science

March 6, 2018

View Archived Issues

Immix studies IMX-110 in patients with advanced solid tumors

Global BioLife completes Zaire Ebola research portion for study of LB-2

CXCR2 targeting suppresses allergic airway inflammation in mice

Magenta and Heidelberg Pharma sign exclusive multi-target research agreement

Zynerba plans pivotal study with ZYN-002 in fragile X syndrome

Vividion and Celgene enter strategic research collaboration

G1 Therapeutics reports phase IIa data on trilaciclib in extensive-stage SCLC

Promising topline data from pivotal phase III study of CLS-TA in uveitic macular edema

AEC syndrome pathology linked to protein aggregation of the p63 transcription factor

Phase III trials of olumacostat glasaretil for acne do not meet co-primary endpoints

FDA grants rare pediatric disease designation to Prometic's inter-alpha inhibitor proteins

Aminoacyclase-1 is a novel potential biomarker for schizophrenia

Enrollment begins in phase I study of treprostinil Technosphere

Safety, eosinophil reductions encourage further development of AK-002

Sorrento reports initial data from phase Ib study of autologous anti-CEA CAR T cells

Enteris signs feasibility development agreement with Ferring

Chi-Med initiates proof-of-concept study of epitinib in glioblastoma

Sanifit completes phase II trial of SNF-472 for calciphylaxis in patients on dialysis

Researchers mimic human walnut allergy in mice

Nightstar Therapeutics initiates phase III STAR trial of NSR-REP1 for choroideremia

Novel tubulin polymerization inhibitors discovered at Athenex

Merck & Co. patents new HCV NS5B inhibitors

Orbis Health Solutions presents anti-CTLA4 and PD-1-encoding bead vectors

Immatics Biotechnologies divulges novel constructs binding COL6A3 antigens

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...